115 research outputs found
You Are What You Eat: Mass spectrometry in paediatric kinetic studies using stable isotopes
An overview will be presented about applications of stable isotopes in paediatric
research. Mass spectrometry has proven to be an essential tool for unravelling
kinetic studies in a large range of different research disciplines related to
intestinal diseases, obesities, severe cerebral palsy, oxidative stress and foetal
metabolism. Due to the diversity and complexity of the different metabolites
involved in these studies, there is a high demand on sophisticated mass
spectrometric instruments. Several new methods have been developed for measurement
of isotopic labelled compounds in body fluids. 13C isotopic glucose enrichment in
human plasma is analysed, using liquid chromatography isotope ratio mass
spectrometry (LC/IRMS). Also new methods were developed for measuring the
glutathione (GSH) fractional synthesis rate (FSR) in neonates after infusion of
[1-13C]glycine as a tracer. For measuring energy expenditure and total body water
composition in humans the doubly labelled water method is valuable technique. It
usually involves blood or urine sampling, which might be difficult in neonates and
children with cerebral palsy or other disabilities. We therefore aimed to validate a
method making use of saliva samples analyzed by automated thermal conversion
elemental analyzer in combination with isotope ratio mass spectrometry (TC/EA/IRMS).
The different types of mass spectrometric instruments will be discussed here as well
as several applications in paediatric research utilizing these techniques. The
applications cover amino acid metabolism and body composition, energy expenditure,
and the synthesis of specific proteins such as glutathione and albumin in different
groups of children and even in foetuses. Finally, the aims and outline of this
dissertation are covered
Milk protein oxidation in healthy subjects:A preliminary study
The role of protein oxidation in the regulation of whole body protein metabolism is unknown. Previously, it was observed that vigorous exercise led to increased protein oxidation. To further characterise 13C-milk protein oxidation in healthy subjects, the oxidation of ingested 13C-protein after an overnight fast was measured using a non-invasive 13C-protein breath test. This approach enables the analysis of 13C-protein oxidation kinetics and the effect of interfering factors. It was found that the estimated maximal 13C-milk protein oxidation was 0.07 g min−1, corresponding to a theoretical maximal oxidation capacity of ≈1.4 g kg body weight−1 d−1. No indications were found for preferential oxidation of non-essential amino acids. Combined ingestion of 30 g 13C-whey protein with 30 g glucose resulted in a 19% decrease of 13C-whey protein oxidation. It was concluded that exogenous 13C-whey protein oxidation can be affected by other co-ingested nutrients like glucose
Bariatric surgery improves postprandial VLDL kinetics and restores insulin mediated regulation of hepatic VLDL production
Dyslipidemia in obesity results from excessive production and impaired clearance of triglyceride-rich (TG-rich) lipoproteins, which are particularly pronounced in the postprandial state. Here, we investigated the impact of Roux-en-Y gastric bypass (RYGB) surgery on postprandial VLDL1 and VLDL2 apoB and TG kinetics and their relationship with insulin-responsiveness indices. Morbidly obese patients without diabetes who were scheduled for RYGB surgery (n = 24) underwent a lipoprotein kinetics study during a mixed-meal test and a hyperinsulinemic-euglycemic clamp study before the surgery and 1 year later. A physiologically based computational model was developed to investigate the impact of RYGB surgery and plasma insulin on postprandial VLDL kinetics. After the surgery, VLDL1 apoB and TG production rates were significantly decreased, whereas VLDL2 apoB and TG production rates remained unchanged. The TG catabolic rate was increased in both VLDL1 and VLDL2 fractions, but only the VLDL2 apoB catabolic rate tended to increase. Furthermore, postsurgery VLDL1 apoB and TG production rates, but not those of VLDL2, were positively correlated with insulin resistance. Insulin-mediated stimulation of peripheral lipoprotein lipolysis was also improved after the surgery. In summary, RYGB resulted in reduced hepatic VLDL1 production that correlated with reduced insulin resistance, elevated VLDL2 clearance, and improved insulin sensitivity in lipoprotein lipolysis pathways.</p
A modified low-protein infant formula supports adequate growth in healthy, term infants:a randomized, double-blind, equivalence trial
Background: A high protein intake in early life is associated with a risk of obesity later in life. The essential amino acid requirements of formula-fed infants have been reassessed recently, enabling a reduction in total protein content and thus in protein intake. Objectives: We aimed to assess the safety of an infant formula with a modified amino acid profile and a modified low-protein (mLP) content in healthy term-born infants. Outcomes were compared with a specifically designed control (CTRL) infant formula. Methods: In this double-blind, randomized controlled equivalence trial, infants received either mLP (1.7 g protein/100 kcal; n = 90) or CTRL formula (2.1 g protein/100 kcal; n = 88) from enrollment (age ≤ 45 d) to 6 mo of age. A breastfed group served as a reference (n = 67). Anthropometry and body composition were determined at baseline, 17 wk (including safety blood parameters), and 6 mo of age. The primary outcome was daily weight gain from enrollment up until the age of 17 wk (at an equivalence margin of ±3.0 g/d). Results: Weight gain from baseline (mean ± SD age: 31 ± 9 d) up to the age of 17 wk was equivalent between the mLP and CTRL formula groups (27.9 and 28.8 g/d, respectively; difference:-0.86 g/d; 90% CI:-2.36, 0.63 g/d). No differences in other growth parameters, body composition, or in adverse events were observed. Urea was significantly lower in the mLP formula group than in the CTRL formula group (-0.74 mmol/L; 95% CI:-0.97,-0.51 mmol/L; P < 0.001). Growth rates, fat mass, fat-free mass, and several essential amino acids were significantly higher in both formula groups than in the breastfed reference group. Conclusions: Feeding an infant formula with a modified amino acid profile and a lower protein content from an average age of 1 mo until the age of 6 mo is safe and supports an adequate growth, similar to that of infants consuming CTRL formula. This trial was registered at www.trialregister.nl as Trial NL4677
Threonine utilization is high in the intestine of piglets
The whole-body threonine requirement in parenterally fed piglets is
substantially lower than that in enterally fed piglets, indicating that
enteral nutrition induces intestinal processes in demand of threonine. We
hypothesized that the percentage of threonine utilization for oxidation
and intestinal protein synthesis by the portal-drained viscera (PDV)
increases when dietary protein intake is reduced. Piglets (n = 18)
received isocaloric normal or protein-restricted diets. After 7 h of
enteral feeding, total threonine utilization, incorporation into
intestinal tissue, and oxidation by the PDV, were determined with stable
isotope methodology [U-(13)C threonine infusion]. Although the absolute
amount of systemic and dietary threonine utilized by the PDV was reduced
in protein-restricted piglets, the percentage of dietary threonine intake
utilized by the PDV did not differ between groups (normal protein 91% vs.
low protein 85%). The incorporation of dietary threonine into the proximal
jejunum was significantly different compared with the other intestinal
segments. Dietary, rather than systemic threonine was preferentially
utilized for protein synthesis in the small intestinal mucosa in piglets
that consumed the normal protein diet (P < 0.05). Threonine oxidation by
the PDV was limited during normal protein feeding. In protein-restricted
pigs, half of the total whole-body oxidation occurred in the PDV. We
conclude that, in vivo, the PDV have a high obligatory visceral
requirement for threonine. The high rate of intestinal threonine
utilization is due mainly to incorporation into mucosal protein
Consideration of influences of soil parameters on compaction behavior with soil/water/air coupled F. E. code
Background: The essential amino acid methionine can be used for protein synthesis but also serves as a precursor for homocysteine and cysteine. Objective: The objective of this study was to determine the minimal obligatory methionine requirement of infants in the presence of excess cysteine (91 mg · k
The Evaluation and Quantitation of Dihydrogen Metabolism Using Deuterium Isotope in Rats
Despite the significant interest in molecular hydrogen as an antioxidant in the last eight years, its quantitative metabolic parameters in vivo are still lacking, as is an appropriate method for determination of hydrogen effectivity in the mammalian organism under various conditions.Intraperitoneally-applied deuterium gas was used as a metabolic tracer and deuterium enrichment was determined in the body water pool. Also, in vitro experiments were performed using bovine heart submitochondrial particles to evaluate superoxide formation in Complex I of the respiratory chain.A significant oxidation of about 10% of the applied dose was found under physiological conditions in rats, proving its antioxidant properties. Hypoxia or endotoxin application did not exert any effect, whilst pure oxygen inhalation reduced deuterium oxidation. During in vitro experiments, a significant reduction of superoxide formation by Complex I of the respiratory chain was found under the influence of hydrogen. The possible molecular mechanisms of the beneficial effects of hydrogen are discussed, with an emphasis on the role of iron sulphur clusters in reactive oxygen species generation and on iron species-dihydrogen interaction.According to our findings, hydrogen may be an efficient, non-toxic, highly bioavailable and low-cost antioxidant supplement for patients with pathological conditions involving ROS-induced oxidative stress
- …